Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Duvall Diantha | Chief Accounting Officer | 20 | $0 | $49.5K | 2018-03-08 |
| DiFabio Andrea | EVP, Chief Legal Officer | 28 | $0 | $0 | 2018-03-08 |
| Celona Lucia | EVP, HR & Corp Commun. Officer | 28 | $0 | $0 | 2018-03-08 |
| Brudnick Richard | EVP, Business Development | 32 | $0 | $0 | 2018-03-08 |
| Greene John | EVP, CFO and Treasurer | 14 | $0 | $0 | 2018-03-08 |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeutics | 14 | $0 | $0 | 2018-03-08 |
| Cox John | Chief Executive Officer | 31 | $0 | $0 | 2018-03-08 |
| Germano Geno J | Director | 4 | $0 | $0 | 2018-03-08 |
| Harris Timothy J.R. | EVP, R & D | 9 | $0 | $0 | 2018-03-08 |
| Posner Brian S | Director | 13 | $166.9K | $0 | 2018-03-08 |
| DENNER ALEXANDER J | Director | 13 | $56.34M | $0 | 2018-03-08 |
| Protopapas Anna | Director | 6 | $0 | $0 | 2018-03-08 |
| PAGLIA LOUIS J | Director | 10 | $234.9K | $0 | 2018-03-08 |
| BIOGEN INC. | 10% Owner | 1 | $0 | $0 | 2017-02-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Brudnick Richard | EVP, Business Development | D To issuer deriv | 2018-03-08 | 2018-03-08 | 29,797 | — | $0 | 0 | SEC↗ |
| Brudnick Richard | EVP, Business Development | D To issuer deriv | 2018-03-08 | 2018-03-08 | 59,595 | — | $0 | 0 | SEC↗ |
| Brudnick Richard | EVP, Business Development | D To issuer deriv | 2018-03-08 | 2018-03-08 | 14,899 | — | $0 | 0 | SEC↗ |
| Brudnick Richard | EVP, Business Development | D To issuer deriv | 2018-03-08 | 2018-03-08 | 31,818 | — | $0 | 0 | SEC↗ |
| Brudnick Richard | EVP, Business Development | D To issuer deriv | 2018-03-08 | 2018-03-08 | 7,489 | — | $0 | 0 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | D To issuer deriv | 2018-03-08 | 2018-03-08 | 7,489 | — | $0 | 0 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | D To issuer deriv | 2018-03-08 | 2018-03-08 | 14,899 | — | $0 | 0 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | D To issuer deriv | 2018-03-08 | 2018-03-08 | 59,595 | — | $0 | 0 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | D To issuer deriv | 2018-03-08 | 2018-03-08 | 29,797 | — | $0 | 0 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | D To issuer deriv | 2018-03-08 | 2018-03-08 | 31,818 | — | $0 | 0 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | D To issuer deriv | 2018-03-08 | 2018-03-08 | 56,615 | — | $0 | 0 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | D To issuer deriv | 2018-03-08 | 2018-03-08 | 113,230 | — | $0 | 0 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | D To issuer deriv | 2018-03-08 | 2018-03-08 | 42,727 | — | $0 | 0 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | D To issuer deriv | 2018-03-08 | 2018-03-08 | 14,230 | — | $0 | 0 | SEC↗ |
| Cox John | Chief Executive Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 193,683 | — | $0 | 0 | SEC↗ |
| Cox John | Chief Executive Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 387,366 | — | $0 | 0 | SEC↗ |
| Cox John | Chief Executive Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 136,364 | — | $0 | 0 | SEC↗ |
| Cox John | Chief Executive Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 48,678 | — | $0 | 0 | SEC↗ |
| Cox John | Chief Executive Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 48,230 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 26,818 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 5,455 | — | $0 | 0 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 7,489 | — | $0 | 0 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 31,818 | — | $0 | 0 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 29,797 | — | $0 | 0 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 29,797 | — | $0 | 0 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 59,595 | — | $0 | 0 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 11,062 | — | $0 | 0 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 7,273 | — | $0 | 0 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 2,780 | — | $0 | 0 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 7,030 | — | $0 | 0 | SEC↗ |
| Germano Geno J | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 21,729 | — | $0 | 0 | SEC↗ |
| Germano Geno J | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 5,455 | — | $0 | 0 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 42,727 | — | $0 | 0 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 113,230 | — | $0 | 0 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 56,615 | — | $0 | 0 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | D To issuer deriv | 2018-03-08 | 2018-03-08 | 14,230 | — | $0 | 0 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | D To issuer deriv | 2018-03-08 | 2018-03-08 | 40,909 | — | $0 | 0 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | D To issuer deriv | 2018-03-08 | 2018-03-08 | 11,271 | — | $0 | 0 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | D To issuer deriv | 2018-03-08 | 2018-03-08 | 33,759 | — | $0 | 0 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | D To issuer deriv | 2018-03-08 | 2018-03-08 | 34,556 | — | $0 | 0 | SEC↗ |
| PAGLIA LOUIS J | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 5,455 | — | $0 | 0 | SEC↗ |
| PAGLIA LOUIS J | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 26,818 | — | $0 | 0 | SEC↗ |
| Posner Brian S | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 2,980 | — | $0 | 0 | SEC↗ |
| Posner Brian S | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 6,364 | — | $0 | 0 | SEC↗ |
| Posner Brian S | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 26,818 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 5,455 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | D To issuer deriv | 2018-03-08 | 2018-03-08 | 23,006 | — | $0 | 0 | SEC↗ |
| Brudnick Richard | EVP, Business Development | D To issuer | 2018-03-08 | 2018-03-08 | 22,952 | — | $0 | 0 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | D To issuer | 2018-03-08 | 2018-03-08 | 20,396 | — | $0 | 0 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | D To issuer | 2018-03-08 | 2018-03-08 | 5,758 | — | $0 | 0 | SEC↗ |
| Cox John | Chief Executive Officer | D To issuer | 2018-03-08 | 2018-03-08 | 185,094 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer | 2018-03-08 | 2018-03-08 | 1,165,000 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer | 2018-03-08 | 2018-03-08 | 5,001 | — | $0 | 0 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | D To issuer | 2018-03-08 | 2018-03-08 | 30,600 | — | $0 | 0 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | D To issuer | 2018-03-08 | 2018-03-08 | 2,791 | — | $0 | 0 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | D To issuer | 2018-03-08 | 2018-03-08 | 5,951 | — | $0 | 0 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | D To issuer | 2018-03-08 | 2018-03-08 | 839 | — | $0 | 0 | SEC↗ |
| PAGLIA LOUIS J | Director | D To issuer | 2018-03-08 | 2018-03-08 | 3,056 | — | $0 | 0 | SEC↗ |
| Posner Brian S | Director | D To issuer | 2018-03-08 | 2018-03-08 | 6,693 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | D To issuer | 2018-03-08 | 2018-03-08 | 1,056 | — | $0 | 0 | SEC↗ |
| PAGLIA LOUIS J | Director | G Gift | 2018-03-05 | 2018-03-08 | 2,000 | — | $0 | 3,056 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | F Tax w/h | 2018-03-02 | 2018-03-05 | 105 | $104.73 | $11.0K | 2,791 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2018-02-23 | 2018-02-26 | 924 | $104.74 | $96.8K | 22,952 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2018-02-23 | 2018-02-26 | 917 | $104.74 | $96.0K | 30,411 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2018-02-23 | 2018-02-26 | 389 | $104.74 | $40.7K | 20,016 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2018-02-23 | 2018-02-26 | 5,794 | $104.74 | $606.9K | 185,094 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2018-02-22 | 2018-02-26 | 1,419 | $104.30 | $148.0K | 23,876 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2018-02-22 | 2018-02-26 | 2,011 | $104.30 | $209.7K | 31,328 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2018-02-22 | 2018-02-26 | 1,235 | $104.30 | $128.8K | 20,405 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2018-02-22 | 2018-02-26 | 13,973 | $104.30 | $1.46M | 190,888 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | F Tax w/h | 2018-02-22 | 2018-02-26 | 168 | $104.30 | $17.5K | 2,896 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | M Exercise deriv | 2018-02-14 | 2018-02-15 | 3,744 | — | $0 | 7,489 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | M Exercise deriv | 2018-02-14 | 2018-02-15 | 3,744 | — | $0 | 7,489 | SEC↗ |
| Cox John | Chief Executive Officer | M Exercise deriv | 2018-02-14 | 2018-02-15 | 24,339 | — | $0 | 48,678 | SEC↗ |
| Brudnick Richard | EVP, Business Development | M Exercise deriv | 2018-02-14 | 2018-02-15 | 3,744 | — | $0 | 7,489 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | M Exercise deriv | 2018-02-14 | 2018-02-15 | 7,114 | — | $0 | 14,230 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | M Exercise deriv | 2018-02-14 | 2018-02-15 | 1,390 | — | $0 | 2,780 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | M Exercise deriv | 2018-02-14 | 2018-02-15 | 7,114 | — | $0 | 14,230 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2018-02-14 | 2018-02-15 | 1,136 | $103.52 | $117.6K | 33,339 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | M Exercise | 2018-02-14 | 2018-02-15 | 3,744 | — | $0 | 34,475 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | M Exercise | 2018-02-14 | 2018-02-15 | 3,744 | — | $0 | 22,781 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2018-02-14 | 2018-02-15 | 1,141 | $103.52 | $118.1K | 21,640 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2018-02-14 | 2018-02-15 | 10,819 | $103.52 | $1.12M | 204,861 | SEC↗ |
| Cox John | Chief Executive Officer | M Exercise | 2018-02-14 | 2018-02-15 | 24,339 | — | $0 | 215,680 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2018-02-14 | 2018-02-15 | 1,137 | $103.52 | $117.7K | 25,295 | SEC↗ |
| Brudnick Richard | EVP, Business Development | M Exercise | 2018-02-14 | 2018-02-15 | 3,744 | — | $0 | 26,432 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | M Exercise | 2018-02-14 | 2018-02-15 | 7,114 | — | $0 | 7,429 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | F Tax w/h | 2018-02-14 | 2018-02-15 | 2,126 | $103.52 | $220.1K | 5,303 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | F Tax w/h | 2018-02-14 | 2018-02-15 | 454 | $103.52 | $47.0K | 3,064 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | M Exercise | 2018-02-14 | 2018-02-15 | 1,390 | — | $0 | 3,518 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | F Tax w/h | 2018-02-14 | 2018-02-15 | 2,118 | $103.52 | $219.3K | 5,496 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | M Exercise | 2018-02-14 | 2018-02-15 | 7,114 | — | $0 | 7,614 | SEC↗ |
| Cox John | Chief Executive Officer | M Exercise deriv | 2018-02-11 | 2018-02-13 | 18,381 | — | $0 | 0 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2018-02-11 | 2018-02-13 | 7,672 | $103.05 | $790.6K | 191,341 | SEC↗ |
| Cox John | Chief Executive Officer | M Exercise | 2018-02-11 | 2018-02-13 | 18,381 | $9.53 | $175.2K | 199,013 | SEC↗ |
| PAGLIA LOUIS J | Director | A Award deriv | 2018-01-31 | 2018-02-02 | 5,455 | — | $0 | 5,455 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award deriv | 2018-01-31 | 2018-02-02 | 31,818 | — | $0 | 31,818 | SEC↗ |
| Cox John | Chief Executive Officer | A Award deriv | 2018-01-31 | 2018-02-02 | 136,364 | — | $0 | 136,364 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award deriv | 2018-01-31 | 2018-02-02 | 31,818 | — | $0 | 31,818 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | A Award deriv | 2018-01-31 | 2018-02-02 | 42,727 | — | $0 | 42,727 | SEC↗ |
| Germano Geno J | Director | A Award deriv | 2018-01-31 | 2018-02-02 | 5,455 | — | $0 | 5,455 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2018-01-31 | 2018-02-02 | 6,364 | — | $0 | 6,364 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award deriv | 2018-01-31 | 2018-02-02 | 5,455 | — | $0 | 5,455 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award deriv | 2018-01-31 | 2018-02-02 | 31,818 | — | $0 | 31,818 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | A Award deriv | 2018-01-31 | 2018-02-02 | 7,273 | — | $0 | 7,273 | SEC↗ |
| Protopapas Anna | Director | A Award deriv | 2018-01-31 | 2018-02-02 | 5,455 | — | $0 | 5,455 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | A Award deriv | 2018-01-31 | 2018-02-02 | 42,727 | — | $0 | 42,727 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | A Award deriv | 2018-01-31 | 2018-02-02 | 40,909 | — | $0 | 40,909 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2017-11-02 | 2017-11-03 | 636 | $53.65 | $34.1K | 30,731 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2017-11-02 | 2017-11-03 | 318 | $53.65 | $17.1K | 18,928 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award | 2017-08-31 | 2017-08-31 | 932 | $56.69 | $52.8K | 1,165,000 | SEC↗ |
| Posner Brian S | Director | P Buy | 2017-08-09 | 2017-08-10 | 1,000 | $59.19 | $59.2K | 6,693 | SEC↗ |
| PAGLIA LOUIS J | Director | P Buy | 2017-08-07 | 2017-08-08 | 2,000 | $59.70 | $119.4K | 5,056 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | S Sale | 2017-06-28 | 2017-06-29 | 818 | $60.47 | $49.5K | 2,128 | SEC↗ |
| DENNER ALEXANDER J | Director | P Buy | 2017-05-30 | 2017-06-01 | 90,000 | $55.93 | $5.03M | 1,165,000 | SEC↗ |
| PAGLIA LOUIS J | Director | P Buy | 2017-05-26 | 2017-05-26 | 2,000 | $57.76 | $115.5K | 3,056 | SEC↗ |
| DENNER ALEXANDER J | Director | P Buy | 2017-05-26 | 2017-05-26 | 450,000 | $57.21 | $25.74M | 1,075,000 | SEC↗ |
| DENNER ALEXANDER J | Director | P Buy | 2017-05-25 | 2017-05-26 | 130,000 | $54.98 | $7.15M | 625,000 | SEC↗ |
| Posner Brian S | Director | P Buy | 2017-05-24 | 2017-05-24 | 700 | $53.79 | $37.7K | 5,693 | SEC↗ |
| Posner Brian S | Director | P Buy | 2017-05-24 | 2017-05-24 | 1,300 | $53.90 | $70.1K | 4,993 | SEC↗ |
| DENNER ALEXANDER J | Director | P Buy | 2017-05-24 | 2017-05-26 | 340,000 | $54.16 | $18.41M | 495,000 | SEC↗ |
| Germano Geno J | Director | A Award deriv | 2017-05-11 | 2017-05-15 | 21,729 | — | $0 | 21,729 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | F Tax w/h | 2017-05-02 | 2017-05-03 | 99 | $57.48 | $5.7K | 2,946 | SEC↗ |
| Posner Brian S | Director | A Award | 2017-04-17 | 2017-04-17 | 1,056 | $56.83 | $60.0K | 3,693 | SEC↗ |
| PAGLIA LOUIS J | Director | A Award | 2017-04-17 | 2017-04-17 | 1,056 | $56.83 | $60.0K | 1,056 | SEC↗ |
| Protopapas Anna | Director | A Award | 2017-04-17 | 2017-04-17 | 1,056 | $56.83 | $60.0K | 1,056 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award | 2017-04-17 | 2017-04-17 | 1,056 | $56.83 | $60.0K | 5,001 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | A Award deriv | 2017-04-10 | 2017-04-11 | 11,271 | — | $0 | 11,271 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | A Award deriv | 2017-04-10 | 2017-04-11 | 33,759 | — | $0 | 33,759 | SEC↗ |
| Harris Timothy J.R. | EVP, R & D | A Award deriv | 2017-04-10 | 2017-04-11 | 34,556 | — | $0 | 34,556 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2017-03-31 | 2017-04-03 | 8,416 | $54.46 | $458.3K | 180,632 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | F Tax w/h | 2017-03-02 | 2017-03-03 | 113 | $52.81 | $6.0K | 3,045 | SEC↗ |
| Cox John | Chief Executive Officer | A Award deriv | 2017-02-28 | 2017-03-02 | 18,381 | — | $0 | 18,381 | SEC↗ |
| Cox John | Chief Executive Officer | A Award deriv | 2017-02-28 | 2017-03-02 | 48,230 | — | $0 | 48,230 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | A Award deriv | 2017-02-28 | 2017-03-02 | 7,030 | — | $0 | 7,030 | SEC↗ |
| Protopapas Anna | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 23,006 | $52.08 | $1.20M | 23,006 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 66 | $43.42 | $2.9K | 23,788 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award | 2017-02-28 | 2017-03-02 | 27,376 | — | $0 | 27,633 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 51 | $43.42 | $2.2K | 27,582 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 22 | $49.56 | $1.1K | 27,560 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 45 | $47.76 | $2.1K | 27,515 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 939 | $43.42 | $40.8K | 26,576 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 411 | $49.56 | $20.4K | 26,165 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 837 | $47.76 | $40.0K | 25,328 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 1,100 | $43.42 | $47.8K | 22,688 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 681 | $47.76 | $32.5K | 23,854 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 339 | $49.56 | $16.8K | 24,535 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 429 | $43.42 | $18.6K | 24,874 | SEC↗ |
| Brudnick Richard | EVP, Business Development | F Tax w/h | 2017-02-28 | 2017-03-02 | 25 | $43.42 | $1.1K | 25,303 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 285 | $49.56 | $14.1K | 32,454 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 918 | $47.76 | $43.8K | 31,536 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 718 | $43.42 | $31.2K | 30,818 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 532 | $43.42 | $23.1K | 32,739 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 1,191 | $47.76 | $56.9K | 33,271 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award | 2017-02-28 | 2017-03-02 | 35,019 | — | $0 | 35,985 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 1,155 | $43.42 | $50.2K | 34,830 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 368 | $49.56 | $18.2K | 34,462 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 2,641 | $49.56 | $130.9K | 202,210 | SEC↗ |
| Cox John | Chief Executive Officer | A Award | 2017-02-28 | 2017-03-02 | 211,679 | — | $0 | 226,979 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 3,404 | $43.42 | $147.8K | 223,575 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 3,383 | $49.56 | $167.7K | 220,192 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 6,726 | $43.42 | $292.0K | 189,048 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 6,436 | $47.76 | $307.4K | 195,774 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 6,986 | $43.42 | $303.3K | 204,851 | SEC↗ |
| Cox John | Chief Executive Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 8,355 | $47.76 | $399.0K | 211,837 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2017-02-28 | 2017-03-02 | 650 | $43.42 | $28.2K | 21,917 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award | 2017-02-28 | 2017-03-02 | 22,567 | — | $0 | 22,567 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2017-02-28 | 2017-03-02 | 235 | $49.56 | $11.6K | 21,682 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2017-02-28 | 2017-03-02 | 768 | $47.76 | $36.7K | 20,914 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2017-02-28 | 2017-03-02 | 301 | $43.42 | $13.1K | 20,613 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2017-02-28 | 2017-03-02 | 790 | $43.42 | $34.3K | 19,049 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2017-02-28 | 2017-03-02 | 592 | $47.76 | $28.3K | 19,839 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | F Tax w/h | 2017-02-28 | 2017-03-02 | 182 | $49.56 | $9.0K | 20,431 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | F Tax w/h | 2017-02-28 | 2017-03-02 | 211 | $47.76 | $10.1K | 3,158 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | A Award | 2017-02-28 | 2017-03-02 | 3,360 | — | $0 | 3,369 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | A Award deriv | 2017-02-14 | 2017-02-16 | 56,514 | — | $0 | 56,514 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | A Award deriv | 2017-02-14 | 2017-02-16 | 113,028 | — | $0 | 113,028 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | A Award deriv | 2017-02-14 | 2017-02-16 | 21,344 | — | $0 | 21,344 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 29,744 | — | $0 | 29,744 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 59,488 | — | $0 | 59,488 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 11,233 | — | $0 | 11,233 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 29,744 | — | $0 | 29,744 | SEC↗ |
| Cox John | Chief Executive Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 193,337 | — | $0 | 193,337 | SEC↗ |
| Cox John | Chief Executive Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 73,017 | — | $0 | 73,017 | SEC↗ |
| Cox John | Chief Executive Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 386,675 | — | $0 | 386,675 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award deriv | 2017-02-14 | 2017-02-16 | 29,744 | — | $0 | 29,744 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award deriv | 2017-02-14 | 2017-02-16 | 11,233 | — | $0 | 11,233 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award deriv | 2017-02-14 | 2017-02-16 | 59,488 | — | $0 | 59,488 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award deriv | 2017-02-14 | 2017-02-16 | 14,872 | — | $0 | 14,872 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award deriv | 2017-02-14 | 2017-02-16 | 59,488 | — | $0 | 59,488 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award deriv | 2017-02-14 | 2017-02-16 | 11,233 | — | $0 | 11,233 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award deriv | 2017-02-14 | 2017-02-16 | 29,744 | — | $0 | 29,744 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award deriv | 2017-02-14 | 2017-02-16 | 14,872 | — | $0 | 14,872 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | A Award deriv | 2017-02-14 | 2017-02-16 | 113,028 | — | $0 | 113,028 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | A Award deriv | 2017-02-14 | 2017-02-16 | 21,344 | — | $0 | 21,344 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | A Award deriv | 2017-02-14 | 2017-02-16 | 56,514 | — | $0 | 56,514 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 11,043 | — | $0 | 11,043 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 4,170 | — | $0 | 4,170 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award deriv | 2017-02-14 | 2017-02-16 | 26,770 | — | $0 | 26,770 | SEC↗ |
| PAGLIA LOUIS J | Director | A Award deriv | 2017-02-14 | 2017-02-16 | 26,770 | — | $0 | 26,770 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2017-02-14 | 2017-02-16 | 26,770 | — | $0 | 26,770 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2017-02-14 | 2017-02-16 | 2,974 | — | $0 | 2,974 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2017-02-14 | 2017-03-27 | 2,980 | — | $0 | 2,980 | SEC↗ |
| Posner Brian S | Director | A Award deriv | 2017-02-14 | 2017-03-27 | 26,818 | — | $0 | 26,818 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award deriv | 2017-02-14 | 2017-03-27 | 26,818 | — | $0 | 26,818 | SEC↗ |
| PAGLIA LOUIS J | Director | A Award deriv | 2017-02-14 | 2017-03-27 | 26,818 | — | $0 | 26,818 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award deriv | 2017-02-14 | 2017-03-27 | 29,797 | — | $0 | 29,797 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award deriv | 2017-02-14 | 2017-03-27 | 14,899 | — | $0 | 14,899 | SEC↗ |
| Celona Lucia | EVP, HR & Corp Commun. Offic | A Award deriv | 2017-02-14 | 2017-03-27 | 59,595 | — | $0 | 59,595 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award deriv | 2017-02-14 | 2017-03-27 | 59,595 | — | $0 | 59,595 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award deriv | 2017-02-14 | 2017-03-27 | 29,797 | — | $0 | 29,797 | SEC↗ |
| Brudnick Richard | EVP, Business Development | A Award deriv | 2017-02-14 | 2017-03-27 | 14,899 | — | $0 | 14,899 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | A Award deriv | 2017-02-14 | 2017-03-27 | 56,615 | — | $0 | 56,615 | SEC↗ |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeuti | A Award deriv | 2017-02-14 | 2017-03-27 | 113,230 | — | $0 | 113,230 | SEC↗ |
| Cox John | Chief Executive Officer | A Award deriv | 2017-02-14 | 2017-03-27 | 387,366 | — | $0 | 387,366 | SEC↗ |
| Cox John | Chief Executive Officer | A Award deriv | 2017-02-14 | 2017-03-27 | 193,683 | — | $0 | 193,683 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award deriv | 2017-02-14 | 2017-03-27 | 29,797 | — | $0 | 29,797 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award deriv | 2017-02-14 | 2017-03-27 | 59,595 | — | $0 | 59,595 | SEC↗ |
| DiFabio Andrea | EVP, Chief Legal Officer | A Award deriv | 2017-02-14 | 2017-03-27 | 29,797 | — | $0 | 29,797 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | A Award deriv | 2017-02-14 | 2017-03-27 | 113,230 | — | $0 | 113,230 | SEC↗ |
| Greene John | EVP, CFO and Treasurer | A Award deriv | 2017-02-14 | 2017-03-27 | 56,615 | — | $0 | 56,615 | SEC↗ |
| Duvall Diantha | Chief Accounting Officer | A Award deriv | 2017-02-14 | 2017-03-27 | 11,062 | — | $0 | 11,062 | SEC↗ |
| BIOGEN INC. | 10% Owner | J Other | 2017-02-01 | 2017-02-01 | 107,975,968 | — | $0 | 0 | SEC↗ |